Inmunoterapia en 1L del CPCNP: monoterapia y/o tratamiento combinado - page 11

1L NSCLC: CheckMate 026
Socinski M, et al. ESMO 2016
1...,2,3,4,5,6,7,8,9,10 12,13,14,15,16,17,18,19,20,21,...42
Powered by FlippingBook